Navigation Links
Rigel Announces Fourth Quarter and Year End 2010 Financial Results
Date:3/1/2011

expects to begin clinical trials with this program, for the potential indication of ventilator associated disuse atrophy (VADA), in late 2012 or 2013.
  • AMPK Activator (Muscle Endurance) - Another aspect of Rigel's muscle metabolism research is focused on activating AMPK, an enzyme that regulates muscle energy and endurance.  As an oral therapy this product candidate may be useful in aiding patients with diseases such as chronic obstructive pulmonary disease (COPD) or chronic heart failure (CHF) and others to regain the physical strength required to sustain everyday life. Rigel expects to begin clinical trials with this program in late 2012 or 2013.

  • About Rigel (www.rigel.com)

    Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that is in clinical trials for asthma.

    This press release contains "forward-looking" statements, including, without limitation, statements related to Rigel's expectations as to its year-end cash position and the sufficiency of its cash, cash equivalents and available for sale securities; identification of a novel programs for clinical development, the potential indications for treatment, and the timing of clinical trials; and the timing of filing a new drug application with respect to fostamatinib. Any statements contained in this press release that are not statement
    '/>"/>

    SOURCE Rigel Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
    2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
    3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
    4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
    5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
    6. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
    7. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
    8. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
    9. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
    10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
    11. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)...  Numotion is pleased to announce the appointment of ... Mark is a 30-year retired veteran of GE ... organization and was a GE Company Officer since 1999 and ... years running business units within GE Healthcare, with the most ... "We are delighted to welcome Mark to our ...
    (Date:9/2/2014)... NEW YORK , Sept. 2, 2014 ... available in its catalogue: Asia - ... http://www.reportlinker.com/p02353212/Asia---Pacific-Minimally-Invasive-Surgery-Spinal-Device-Market.html The growth rate ... MIS spinal device market will remain at double-digit levels ... spinal surgeries as the future of this field. The ...
    (Date:9/2/2014)... Sept. 2, 2014 Depomed, Inc. (Nasdaq: ... offer, subject to market and other conditions, $230 million ... (the "Notes"). Depomed, Inc. ("Depomed") expects to grant the ... up to an additional $34.5 million aggregate principal amount ... RBC Capital Markets, LLC will act as joint book-running ...
    Breaking Medicine Technology:Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3
    ... Decision Resources, one of the world,s leading research ... that biosimilar insulins and insulin analogues stand to erode ... Europe (France, Germany, Italy, Spain and U.K.) by 2018, ... , As insulins are relatively easy to develop and ...
    ... Corporation (Nasdaq: SMTS ) today announced that it ... Partners II, LLC ("Raba coreFoundry"). Under terms of ... specified rights of the U.S. Government and rights retained ... technology developed at The Johns Hopkins University. Integration ...
    Cached Medicine Technology:Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 2Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
    (Date:9/2/2014)... Fla. (PRWEB) September 02, 2014 ... join together in Tampa Bay from September 4-6 ... annual Scientific Symposium and FARA Energy Ball Gala. ... USF Ataxia Research Center in their pursuit of ... affected by the progressive neuromuscular disease Friedreich’s ataxia ...
    (Date:9/2/2014)... Los Angeles, CA (PRWEB) September 03, 2014 ... helps health enthusiasts, bodybuilders, and athletes obtain the ... announced its launch. The site, which focuses mainly ... is dedicated to helping individuals increase their workout ... to an article available on Top Creatine Monohydrate, ...
    (Date:9/2/2014)... UWDress.com, an experienced supplier of wedding dresses and women’s ... bridesmaid dresses for 2014 to its product ... offer to celebrate the coming autumn. All clients can ... off. , The company’s sales representative says, “We ... dresses for consumers from every part of the world. ...
    (Date:9/2/2014)... September 02, 2014 Becker's Healthcare ... Center Educational Program on October 23-25, 2014 at ... Annual Meeting - The Business and Operations of ... through high-quality continuing education, networking events, and an ... technologies. , Outstanding educational offerings throughout the three-day ...
    (Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in the ... strand woven bamboo floors to celebrate the coming ... appreciation to the frequent callers, BambooIndustry.com launched a promotion ... to strand woven floors, BambooIndustry.com provides many kinds of ... click strand woven floors, click lock floors, wide plank ...
    Breaking Medicine News(10 mins):Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 3Health News:Creatine Monohydrate Reviews Site TopCreatineMonohydrate.com Announces its Launch 2Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 3Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2
    ... CIA Interrogation Tactics Confirms Severe and Long-Lasting Harm of Techniques ... ... 17, 2009 -- The newly released Bush Administration,s Office of ... involvement of health professionals in designing, supervising and implementing the ...
    ... Trauma Center and Neurological Intensive Care UnitATLANTA, April 17 ... gift to Grady Health System to improve emergency care ... The gift will enable Grady to expand hospital ... time-dependent therapies for stroke and acute neurological emergencies. ...
    ... SINGAPORE, April 17 /PRNewswire-Asia/ -- GfK Asia is pleased ... for the optical,industry today in line with the 14th ... to our recent survey in Malaysia, 25% of,consumers visit ... close to the,Asian average of 28%. "Despite the current ...
    ... cancer are well known, the risks they confer are ... access journal BMC Medicine describes the exact ... of colorectal cancer in a large group of patients. ... from the Universities of Bristol and Birmingham who studied ...
    ... Aurora Health Care ... replacement this morning. This first, in Wisconsin, ... reach thousands of viewers. (Photo: http://www.newscom.com/cgi-bin/prnh/20090416/CG00542 ... Aurora caregivers posted updates as "tweets" and answered ...
    ... SAN DIEGO, Calif., April 16 Join San Diego ... across the country, in making future healthcare decisions known ... Decisions Day is April 16. Now is a great ... directive, because... YOUR DECISIONS MATTER. What is ...
    Cached Medicine News:Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 2Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 3Health News:The Marcus Foundation Gives $20 Million to Grady Health System 2Health News:The Marcus Foundation Gives $20 Million to Grady Health System 3Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 2Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 3Health News:Colorectal cancer risks quantified 2Health News:Aurora Health Care Twitter-Surgery A Success 2Health News:Your Decisions Matter: San Diego Hospice Encourages You to Make Your Healthcare Decisions Known 2
    ... Chrome-plated metal frames ... ensures optimal cleanliness and ... stools come with user-friendly ... height adjustment. Fixed footring ...
    ... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
    ... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
    Inquire...
    Medicine Products: